Search for: "Brooks v. Holman"
Results 1 - 20
of 26
Sorted by Relevance
|
Sort by Date
4 Aug 2022, 2:10 pm
The post Case Comment: Holman v Brooke, 2022 BCSC 526 appeared first on McLarty Wolf. [read post]
9 Apr 2009, 7:52 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US CAFC clarifies obviousness standard in context of cDNA cloning invention: In re Kubin (Holman's Biotech IP Blog) (Patent Docs) (Hal Wegner) (Philip Brooks' Patent Infringement Updates) (Patently-O) (Patent Docs) Xigris (Drotrecogin alfa) –US: CAFC: Pioneering claims require more expansive written… [read post]
27 Oct 2010, 3:38 am
Highlights this week included: CAFC: Patentability of isolated genes Association for Molecular Pathology v USPTO and Myriad Genetics – Myriad files brief (Patently-O) (Holman’s Biotech IP Blog) (Holman’s Biotech IP Blog) Glivec (Imatinib) – Brazil: Supreme Court of Justice denies extension of Glivec patent (IP tango) Plavix (Clopidogrel) – US: $442 million fine against Apotex for Plavix patent infringement (GenericsWeb) (Philip… [read post]
30 Jan 2009, 9:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: AIPLA urges Federal Circuit not to proscribe patents for biomedical diagnostic tools: Prometheus v Mayo (Inventive Step) (Hal Wegner) (Patently-O) (Holman's Biotech IP Blog) Lovenox (Enoxaparin) – US: Aventis files for certiorari: challenging Federal Circuit’s low standard for intent to deceive in… [read post]
10 Oct 2008, 11:32 am
:Interpharma Pty Ltd v Commisioner of Patents (GenericsWeb) Gemzar (Gemcitabine) - US: Eli Lilly sues Teva for patent infringement and seek declaratory judgment (The IP Factor) (Law360) Glivec (Imatinib) - India: Supreme Court appoints Dr Chakraborty as technical member on IPAB panel hearing Glivec appeal (Spicy IP) Jeevani (Arogyapacha) - India: Recent developments in the Arogypacha case (Spicy IP) Miralax (Polyethylene glycol) - US: 'Advice of scientist' defense… [read post]
13 Feb 2009, 5:00 am
(Profitability through Simplicity) Patent World SPC round-up ‘Prolonging Patent Protection’ by Marjan Noor (SPC Blog) EU: Commission’s view on paediatric extensions (The SPC Blog) EU: Suing, not suing both attract the Commission’s attention – EU pharma inquiry (PatLit) EU: Life Science marks held confusingly similar: Bayern Innovativ – Bayerische Gesellschaft für Innovation und Wissenstransfer mbH, v Office for… [read post]
10 May 2015, 5:48 pm
’s Office v. [read post]
9 Aug 2008, 1:50 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: The end of William Patry’s blog: (Patry Copyright Blog), (Excess Copyright), (Patently-O), (Chicago IP Litigation Blog), (Michael Geist), (The Fire of Genius), (Techdirt), (Patry Copyright Blog), Kitchin J clarifies scope of biotech patents, in particular gene sequence patents: Eli Lilly & Co v Human Genome Sciences:… [read post]
29 Aug 2008, 1:25 pm
– Discussion of IPFrontline.com article ‘Understanding Intellectual Property Value’: (IP finance), How to make sure your IP strategy plan is not doomed to failure: (IP Asset Maximizer Blog) Improve venture capital returns with IP portfolio management: (Ezine @rticles) Global - Trade Marks / Domain Names / Brands Trade mark strategy – counterintuitive names: (IP Thinktank), ICANN Intellectual Property Constituency paper on sunrise mechanisms for… [read post]
14 Dec 2007, 1:00 am
: (Holman), (IAM), Will Macrovision's acquisition of Gemstar result in a more aggressive IP Strategy in future? [read post]
9 May 2008, 10:30 pm
: (Ezine @rticles) Global - Patents Rise of machine translation services: (IPKat), USPTO / EPO / JPO progress on ‘common application format’ for expedited examination: (Peter Zura's 271 Patent Blog), Proponents: ‘Time is now’ for TRIPs biodiversity amendment in Doha round: (Intellectual Property Watch), TRIPs amendment in favour of disclosures for genetic resources/traditional knowledge patents gathers support: (Afro-IP), WIPO… [read post]
28 Apr 2008, 11:00 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: CAFC vacates FTC’s decision that Rambus breached antitrust duty by violating JEDEC patent disclosure rules and orders new trial: (Philip Brooks), (Techdirt), (Ars Technica), (IP Law360), (Peter Zura's 271 Patent Blog), (Hal Wegner), (IPBiz), (IP Law360), UK Court of Appeal rules on whether prior art not in the same design… [read post]
13 Jun 2008, 3:40 am
, Schering-Plough Corp – Following dispute over trade dress with Schering-Plough, Fruit of the Earth announces plan to change its package design: (IP Law360), US: Quanta and its impact on biotechnology: (Holman’s Biotech IP Blog), US: BIO files amicus brief asking CAFC to cabin in scope of KSR and hold that its obvious to try dicta does not abrogate the Deuel standard: In re Kubin: (Patently-O), US: StemCells gets patent on enriched central nervous system stem cell and… [read post]
8 Feb 2008, 7:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included:Record labels sue Baidu over providing links to file-sharing sites: (Ars Technica), (Techdirt), (Out-Law), (IP Law360), (Copyfight), Merck’s Fosamax patent expires: Watson Pharmaceuticals to distribute authorized generic version, Teva and Barr also launch FDA approved generic versions: (SmartBrief), (Patent Circle), (In … [read post]
29 Feb 2008, 8:00 am
, (EDTexweblog.com), (Patent Prospector), (Peter Zura's 271 Patent Blog), (IPBiz), (Against Monopoly), (Philip Brooks), (IPBiz), Indian government to consider whether to grant compulsory licenses to Natco for the exportation of generic versions of Tarceva and Sutent (Sunitinib) to Nepal : (Spicy IP), (Spicy IP), (Spicy IP), (Generic Pharmaceuticals & IP), (IP Law360), (Spicy IP),GlobalGlobal - GeneralIntellectual privilege or imaginary property? [read post]
12 Sep 2008, 2:33 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Australian Review of National Innovation System released: (IPRoo), (Mallesons Stephen Jaques), (creativecommons.org), (IP Menu News), Senate Committee on the Judiciary approval of Enforcement of Intellectual Property Rights Act 2008 and surrounding debate (Law360), (Public Knowledge), (Ars Technica), (Wired), (Public Knowledge), (Ars Technica),… [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its… [read post]
7 Mar 2008, 2:00 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: USPTO upholds one of Wisconsin Alumni Research Foundation (WARF’s) human stem cell patents (decisions are pending on two other patents): (IPKat), (Patent Prospector), (IPBiz), (IPBiz), (IPBiz), (Patent Baristas), (IPBiz), English High Court rules Qualcomm’s patents invalid in battle against Nokia: (Philip Brooks),… [read post]
23 Dec 2007, 8:00 pm
: (IPEG),More on the implementation of the London Agreement and patent cost reduction in Europe: (Patent Baristas),ECJ rules that EU legislative obligations cannot be enforced in any Member State if that legislation has not been published in the Official Journal in the language of that Member State (Case C-161/06 OlomoucSkoma-Lux sro v Celni reditelstvi Olumouc): (IPKat),EPO fighting complex appl [read post]
15 Feb 2008, 9:00 am
: (Spicy IP),USD 20 billion going off-patent: (Patent Circle),Canadian Prices Review Board asserts jurisdiction over products sold in US, but imported into Canada under Special Access Program: (Gowlings),Canadian Court of Appeal affirms decision allowing patent-owner to be joined to proceedings: Cobalt v Pfizer and Pharmascience v Pfizer: (Gowlings),PharmaStem appeals stem cell patent: asks for greater deference to patent examiners:… [read post]
